Clinical Trials Browser

Phase 3 × NETWORK × Carnitine × Clear all

NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00091169 2023-07-05

Levocarnitine in Treating Fatigue in Cancer Patients

Phase 3 Completed

376 enrolled 11 charts

Systemic carnitine deficiency, Depression, Fatigue, Pain